COMP <GO>
KROS vs BBOT // EV/EBITDA & P/E VALUATION
Keros Therapeutics Inc. (NASDAQ) VS. BridgeBio Oncology Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: KROS 4
— BBOT 0
■ METRIC PARITY
LAST: $11.04 (-2.82%) • MKT CAP: $225.2M
valuation
—
LAST: $2.62 (-2.96%) • MKT CAP: $216.5M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KROS VS. BBOT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KROS | BBOT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | -35.00% | +120.00 | KROS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 27.70% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 35.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.31 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 2/9 | +6.00 | KROS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.6 | 24.1 | +16.52 | KROS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $225.2M | $216.5M | $8.8M | KROS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KROS REV | BBOT REV | KROS GROSS % | BBOT GROSS % | KROS FCF | BBOT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $244.1M | $0 | — | — | $106.0M | -$114.5M |
| FY 2024 | $3.5M | $0 | — | — | -$162.8M | -$55.1M |
| FY 2023 | $151.0K | $0 | — | — | -$124.5M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KROS // BETA —
BBOT // BETA —